Discovery
Showing of 16 results
Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center.
Grateful Champions of Care, Brennan Family Supports UH Transplant Institute
The Brennan family’s gift accelerates UH transplant innovation and honors the care that Nancy Brennan received, while also highlighting her own life of service.
Christine’s Way to Healing Supports UH Neurological Institute’s Peripheral Nerve Surgery Center
How one woman’s vivacity and care for others will now help patients facing a rare muscle disease.
UH Leading the Way in AI-Assisted Healthcare
Artificial intelligence (AI), the transformative data-driven technology that emulates human brain power, is revolutionizing the healthcare landscape.
Gifts Pump Cardiovascular Innovation at UH Harrington Heart & Vascular Institute
UH Harrington Heart & Vascular Institute is setting new care standards with donor support for world-class physician–scientists. Recent gifts have established or elevated four endowed positions that will fuel research, education and patient care.
Roe Green Scholar Creates Surgical Teaching App
Rachel Pope, MD, MPH, an obstetrician/gynecologist at the UH Urology Institute and a UH Roe Green Global Health Scholar, is fellowship-trained in global women’s health. She recently developed an app to help train more physicians in fistula repairs.
Groundbreaking Study Shows Alzheimer’s Disease Can Be Reversed in Animal Models
A new study led by UH’s Andrew Pieper, MD, PhD and his team is changing how we think about Alzheimer’s disease. The team has confirmed in animal models that restoring the brain’s energy balance not only stops the disease, but also reverses damage.
Breakthrough Heart Attack Treatment Moves into Clinical Trials
A promising new medicine for heart attack patients has reached a major milestone: successful results in a pivotal Phase 3 clinical trial. Support from Harrington Discovery Institute at University Hospitals helped make the achievement possible.